Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.60 | -$0.60 | -$0.60 |
| Q2 2026 | 1 | -$0.80 | -$0.80 | -$0.80 |
| Q3 2026 | 1 | -$0.70 | -$0.70 | -$0.70 |
| Q4 2026 | 1 | -$0.40 | -$0.40 | -$0.40 |
Bio-Key International Inc. last posted its earnings results on Tuesday, March 31st, 2026. The company reported $-1.9 earnings per share for the quarter, missing analysts' consensus estimates of $-0.7 by $1.2. The company had revenue of 1.24 M for the quarter and had revenue of 6.10 M for the year. Bio-Key International Inc. has generated $-7 earnings per share over the last year ($-6.9 diluted earnings per share) and currently has a price-to-earnings ratio of -0.5. Bio-Key International Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q4 2025 | -$0.70 | -$2.60 | -1.9 | $2.20 M | $1.24 M |
| 11/14/2025 | Q3 2025 | -$0.12 | -$1.50 | -1.38 | $1.80 M | $1.55 M |
| 08/13/2025 | Q2 2025 | -$0.15 | -$2.00 | -1.85 | $1.70 M | $1.70 M |
| 05/15/2025 | Q1 2025 | -$0.24 | -$1.60 | -1.36 | $1.30 M | $1.61 M |
| 04/23/2025 | Q4 2024 | N/A | -$5.20 | N/A | $2.30 M | $1.46 M |
| 11/14/2024 | Q3 2024 | -$0.39 | -$3.90 | -3.51 | $2.14 M | $2.14 M |
| 08/14/2024 | Q2 2024 | N/A | -$10.00 | N/A | $2.00 M | $1.14 M |
| 06/14/2024 | Q1 2024 | N/A | -$3.20 | N/A | $3.70 M | $2.18 M |
| 06/05/2024 | Q4 2023 | N/A | -$116.10 | N/A | $2.20 M | $925.10 K |
| 11/20/2023 | Q3 2023 | N/A | -$32.20 | N/A | $1.50 M | $1.82 M |
| 08/18/2023 | Q2 2023 | N/A | -$47.10 | N/A | $2.20 M | $1.93 M |
| 06/09/2023 | Q1 2023 | N/A | -$35.10 | N/A | $2.00 M | $2.18 M |
| 06/01/2023 | Q4 2022 | N/A | -$111.80 | N/A | $1.74 M | $1.76 M |
| 11/14/2022 | Q3 2022 | -$2.88 | -$53.10 | -50.22 | $2.40 M | $1.37 M |
| 08/17/2022 | Q2 2022 | N/A | -$38.20 | N/A | $2.50 M | $1.95 M |
| 05/23/2022 | Q1 2022 | N/A | -$22.80 | N/A | $1.25 M | $1.94 M |
| 03/31/2022 | Q4 2021 | N/A | -$46.80 | N/A | $1.40 M | $934.93 K |
| 11/15/2021 | Q3 2021 | -$0.11 | -$23.70 | -23.59 | $1.50 M | $1.30 M |
| 08/16/2021 | Q2 2021 | -$0.11 | -$26.90 | -26.79 | $1.95 M | $992.09 K |
| 05/17/2021 | Q1 2021 | N/A | -$19.70 | N/A | $1.25 M | $1.89 M |
The conference call for Bio-Key International Inc.'s latest earnings report can be listened to online.
The conference call transcript for Bio-Key International Inc.'s latest earnings report can be read online.
Bio-Key International Inc. (:BKYI) has a recorded annual revenue of $6.10 M.
Bio-Key International Inc. (:BKYI) has a recorded net income of $-4,590,370.Bio-Key International Inc. has generated $-6.9 earnings per share over the last four quarters.
Bio-Key International Inc. (:BKYI) has a price-to-earnings ratio of -0.5 and price/earnings-to-growth ratio is -0.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED